Altimmune, Inc. Alternatives & Competitors
12 companies similar to Altimmune, Inc. — Late clinical-stage biotech working to improve the lives of those living with se...
Companies similar to Altimmune, Inc.
NeuroSense Therapeutics
Creatively and diligently moving fast towards an effective treatment for people with ALS.
Cambridge, United States
AusperBio
Transforming Patient Lives For a Better Tomorrow
San Mateo, United States
Antag Therapeutics
Redefining obesity treatment, empowering patients
Denmark
Skye Bioscience Inc.
Unlocking new therapeutic pathways for metabolic health
San Diego, United States
Track all Altimmune, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
BioMarin Pharmaceutical Inc.
We transform lives through genetic discovery.
San Rafael, United States
Akero Therapeutics
Restoring Balance. Renewing Life.
South San Francisco, Unit...
Upstream Bio
Developing treatments for inflammatory diseases
Waltham, United States
Yaqrit
The Liver Disease Company
London, United Kingdom
BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
Cambridge, United States
Alentis Therapeutics
We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis
Allschwil, Switzerland
Madrigal Pharmaceuticals
Madrigal is focused on delivering novel therapeutics for MASH, a serious liver disease.
Conshohocken, United Stat...
GENFIT
Dedicated to improving the lives of patients with liver diseases characterized by high unm...
Loos, France
About Altimmune, Inc.
Altimmune, Inc., founded in 1997, is a promising player in the biopharmaceutical sector, carving a niche in the treatment of liver-related diseases. Describing themselves as a "Late clinical-stage biotech working to improve the lives of those living with serious liver diseases," they focus on developing advanced therap...
development of peptide-based therapeutics, clinical stage research, drug development for liver diseases
patients with metabolic dysfunction-associated steatohepatitis, patients with alcohol use disorder, patients with alcohol-associated liver disease, healthcare providers, biopharmaceutical investors
Biopharmaceuticals, Liver Diseases, Clinical-Stage, MASH Therapy, AUD Treatment, ALD Therapy, Glucagon Receptor, GLP-1 Receptor, Dual-Action Therapy, Metabolic Dysfunction, Steatohepatitis, Alcohol Use Disorder, Liver Health
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Altimmune, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Altimmune, Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 7 Jun 2025 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
